Surmodics Stock

Surmodics Liabilities 2024

Surmodics Liabilities

65.82 M USD

Ticker

SRDX

ISIN

US8688731004

WKN

914178

In 2024, Surmodics's total liabilities amounted to 65.82 M USD, a 31.65% difference from the 50 M USD total liabilities in the previous year.

Surmodics Aktienanalyse

What does Surmodics do?

Surmodics Inc is an American company specializing in medical technology, based in Eden Prairie, Minnesota. They focus on developing and commercializing technologies to improve disease diagnosis and treatment. The company offers a wide range of medical devices and solutions for various medical applications, including cardiology, radiology, oncology, ophthalmology, and pharmaceutical development. Surmodics operates in three main business areas: medical devices, hollow fiber technology, and bioactive coatings. Their products are designed to meet the specific needs of customers and medical applications. Surmodics has a strong global presence and has expanded through strategic acquisitions in recent years, particularly in the pharmaceutical development and hollow fiber technology sectors. Surmodics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Surmodics's Liabilities

Surmodics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Surmodics's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Surmodics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Surmodics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Surmodics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Surmodics stock

What is the level of liabilities of Surmodics this year?

Surmodics has a debt balance of 65.82 M USD this year.

What were the liabilities of Surmodics compared to the previous year?

The liabilities of Surmodics have increased by 31.65% increased compared to the previous year.

What are the consequences of high debt for investors of Surmodics?

High liabilities can pose a risk for investors of Surmodics, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Surmodics?

Low liabilities mean that Surmodics has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Surmodics affect the company?

An increase in liabilities of Surmodics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Surmodics affect the company?

A decrease in the liabilities of Surmodics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Surmodics?

Some factors that can influence the liabilities of Surmodics include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Surmodics so important for investors?

The liabilities of Surmodics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Surmodics take to modify the liabilities?

To change its liabilities, Surmodics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Surmodics pay?

Over the past 12 months, Surmodics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Surmodics is expected to pay a dividend of 0 USD.

What is the dividend yield of Surmodics?

The current dividend yield of Surmodics is .

When does Surmodics pay dividends?

Surmodics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Surmodics?

Surmodics paid dividends every year for the past 0 years.

What is the dividend of Surmodics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Surmodics located?

Surmodics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Surmodics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Surmodics from 10/6/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/6/2024.

When did Surmodics pay the last dividend?

The last dividend was paid out on 10/6/2024.

What was the dividend of Surmodics in the year 2023?

In the year 2023, Surmodics distributed 0 USD as dividends.

In which currency does Surmodics pay out the dividend?

The dividends of Surmodics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Surmodics

Our stock analysis for Surmodics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Surmodics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.